RxDoctor Payments Data

Brandon Larsen, PA

Medical · Idaho Falls, IDNPI 1215523337

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 27.8% of the total. Among medical clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,966in general payments, 2019–2025

Across 163 payments — averaging $30.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • AbbVie$1K
  • Johnson & Johnson$482
  • Vanda Pharmaceuticals Inc.$455
  • E.r. Squibb & Sons, L.L.C.$249
  • Actelion Pharmaceuticals US, Inc.$243
  • plus $889 from 15 others

What the payments were for

  • Food & beverage$4,966100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,966 in reported general payments places this provider in the 90th percentile of 265 medical providers in Idaho.

See all medical providers in Idaho

Medicare billing

Part B allowed, 2024
$6,739
Medicare patients
22
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl90$110,894
SpravatoEsketamine Hcl17$21,385
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl47$5,992
Aripiprazole25$4,513
Atomoxetine Hcl38$4,325
Lurasidone Hcl23$3,194
Clozapine27$1,265
Olanzapine31$1,244
Vilazodone Hcl13$1,002
Venlafaxine Hcl ErVenlafaxine Hcl27$942
Quetiapine Fumarate95$827
Buspirone Hcl71$762
Duloxetine Hcl26$683
Prazosin Hcl31$638
Amitriptyline Hcl16$617

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,265$110,89490 claims
Johnson & JohnsonSpravato$482$21,38517 claims
Lilly USA, LLCOlanzapine$16$1,24431 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 265 medical providers in Idaho.

Other medical in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →